Transfer of technolgy and added value: No contradiction for DexLeChem

During a panel discussion at the German Biotechnologietage in Hamburg on April 9  (13.30 to 15.00 h), Jost is talking on the transfer of technology and its general conditions from a spin-off point of view. DexLeChem is offering a real innovation opportunity and the chance to create economic value for the chemical and pharmaceutical industry.

Go back